FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies - FDA.gov

1. FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies  FDA.gov
2. FDA: Take time to make sure your diversity guidance is solid | STAT  STAT
3. Centering underrepresented populations in pharmacy research | Waterloo News  University of Waterloo
4. One-Third of Interviewed Executives Explicitly Mention Mistrust in the Healthcare System as a Significant Barrier to Diverse Enrollment in Clinical Trials  Joplin Globe
5. Black and Latino patients are rarely part of clinical studies. Why?  KCRW